Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Comment: Transplantation and short telomeres increase the risk of cognitive impairment

Dr Jeffrey Miller - University of Minnesota, Minneapolis, USA
Comment: Transplantation and short telomeres increase the risk of cognitive impairment ( Dr Jeffrey Miller - University of Minnesota, Minneapolis, USA )
17 Dec 2013

Equality of access to transplant for ethnic minority patients

Dr Robert Lown - Royal Marsden Hospital, London, UK
Equality of access to transplant for ethnic minority patients ( Dr Robert Lown - Royal Marsden Hospital, London, UK )
17 Dec 2013

New agents in CLL

Dr Jacqueline Barrientos - LIJ Medical Center, New York, USA
New agents in CLL ( Dr Jacqueline Barrientos - LIJ Medical Center, New York, USA )
13 Dec 2013

Full-intensity transplantation and short telomeres increase risk of cognitive impairment after allogeneic haematopoietic cell transplantation

Dr Smita Bhatia - City of Hope National Medical Center, Duarte, USA
Full-intensity transplantation and short telomeres increase risk of cognitive impairment after allogeneic haematopoietic cell transplantation ( Dr Smita Bhatia - City of Hope National Medical Center, Duarte, USA )
13 Dec 2013

Targeting tyrosine kinase receptors to tackle CML

Prof Michael Deininger - University of Utah, Salt Lake City, USA
Targeting tyrosine kinase receptors to tackle CML ( Prof Michael Deininger - University of Utah, Salt Lake City, USA )
13 Dec 2013

Chronic lymphocytic leukaemia: A new treatment era is born

Dr John Gribben - Barts Cancer Institute, London, UK
Chronic lymphocytic leukaemia: A new treatment era is born ( Dr John Gribben - Barts Cancer Institute, London, UK )
13 Dec 2013

Chemo-free treatment for acute promyelocytic leukaemia

Dr Luca Mazzarella - European Institute of Oncology, Milan, Italy
Chemo-free treatment for acute promyelocytic leukaemia ( Dr Luca Mazzarella - European Institute of Oncology, Milan, Italy )
13 Dec 2013

Initial phase III results of the first trial in newly diagnosed multiple myeloma

Dr Thierry Facon - Centre Hospitalier Régional Universitaire de Lille, France
Initial phase III results of the first trial in newly diagnosed multiple myeloma ( Dr Thierry Facon - Centre Hospitalier Régional Universitaire de Lille, France )
10 Dec 2013

Lenalidomide promotes CRBN-mediated ubiquitination and degradation of IKZF1 and IKZF3

Dr Jan Krönke - Brigham and Women's Hospital, Boston, USA
Lenalidomide promotes CRBN-mediated ubiquitination and degradation of IKZF1 and IKZF3 ( Dr Jan Krönke - Brigham and Women's Hospital, Boston, USA )
8 Dec 2013

Treating ALL patients with T cells targeted for CD19

Dr Laurence Cooper - MD Anderson Cancer Center, Houston, USA
Treating ALL patients with T cells targeted for CD19 ( Dr Laurence Cooper - MD Anderson Cancer Center, Houston, USA )
8 Dec 2013

Long-term functional persistence, B cell aplasia and anti-leukaemia efficacy in refractory B cell malignancies

Dr Michael Kalos - University of Pennsylvania, Philadelphia, USA
Long-term functional persistence, B cell aplasia and anti-leukaemia efficacy in refractory B cell malignancies ( Dr Michael Kalos - University of Pennsylvania, Philadelphia, USA )
8 Dec 2013

T cells engineered with chimeric antigen receptor targeting CD19 produce significant long-term persistence

Dr Stephen A. Grupp - University of Pennsylvania, Philadelphia, USA
T cells engineered with chimeric antigen receptor targeting CD19 produce significant long-term persistence ( Dr Stephen A. Grupp - University of Pennsylvania, Philadelphia, USA )
8 Dec 2013